The FDA has approved Orzeyful (oveporexton) tablets to treat narcolepsy type 1 in adults, marking the first therapy approved to treat the full range of symptoms associated with the disorder and the first to target its underlying biological cause. Unlike…

U.S. News and World Report’s 2026-2027 Best Hospitals Honor Roll recognizes 20 hospitals, and each relies on a chief pharmacy officer overseeing medication safety, drug supply and formulary strategy at enormous scale. U.S. News evaluated nearly 4,500 hospitals across 14…

The FDA has approved Moderna’s mFLUSIVA (mRNA-1010), the first mRNA-based influenza vaccine in the U.S., for the prevention of seasonal influenza in adults ages 50 and older. The decision follows a monthslong regulatory process that included the agency’s initial refusal…

Prescription drug spending has become increasingly concentrated on highly novel medicines over the last decade, driven by greater prescribing rather than higher prices, according to a study published Aug. 3 in Health Affairs.  Researchers at the USC Schaeffer Center for…

Omaha-based University of Nebraska Medical Center College of Pharmacy has received Accreditation Council for Pharmacy Education approval to offer an extended PharmD curriculum. Beginning in 2027, the college will become the second public university in the country to enroll students…

The End Drug Shortages Alliance has released new research examining the effects of recurring shortages of injectable hydromorphone, morphine and fentanyl on hospitals, clinicians and patients. The report draws on interviews with healthcare supply chain stakeholders and survey responses from…

Nearly 1 in 6 medications discontinued or reduced during hospitalization were restarted within 90 days among older adults discharged to skilled nursing facilities, according to a study published June 8 in JAMA Network Open. Researchers analyzed data from two randomized…

Network Health, the insurance arm of Wisconsin-based Froedtert ThedaCare Health, is expanding its partnership with Mark Cuban Cost Plus Drug Co. to include employer-sponsored health plan members. In early 2025, Network Health became one of the first insurers in the…

The WVU Heart and Vascular Institute and the West Virginia University School of Pharmacy in Morgantown are expanding a program that connects patients with heart failure in rural communities to specialized cardiovascular care through local pharmacies. The program now includes…

AstraZeneca has held talks with Bristol Myers Squibb about a potential merger that would create one of the world’s largest drugmakers with a combined market value of nearly $400 billion, according to an Aug. 2 report from Financial Times. The…